Our product range includes a wide range of dapagliflozin sitagliptin metformin tablets, sitagliptine dapagliflozin and metformin hcl er 500, dapagliflozin metformin hcl er tablets, voglibose repaglinide tablets, vildagliptin tablets 50mg and dapagliflozin sitagliptin phosphate tablets.
Dapagliflozin + Metformin + Sitagliptin is a combination of three antidiabetic medicines. Dapagliflozin increases urinary glucose excretion and reduces blood glucose levels. Metformin decreases the amount of glucose you absorb from your food and the amount of glucose made by the liver.
Request Callback
Yes! I am Interested
Sitagliptine Dapagliflozin and metformin HCL ER 500
drugs—Dapagliflozin, Sitagliptin, and Metformin—used to manage type 2 diabetes mellitus. Dapagliflozin helps by increasing the amount of sugar excreted through urine, while Metformin reduces sugar production by the liver and improves insulin sensitivity. Sitagliptin works by increasing insulin release from the pancreas after meals.
Dapagliflozin and metformin combination is used together with proper diet and exercise to treat type 2 diabetes. It is also used to lower the risk of hospitalization for heart failure in patients with type 2 diabetes and cardiovascular (heart or blood vessel) disease or multiple cardiovascular risk factors ...
Voglibose + Repaglinide tablets, such as Volga R 0.3/1, are a combination medication used to manage type 2 diabetes. Voglibose, an alpha-glucosidase inhibitor, slows down carbohydrate digestion, while repaglinide, a meglitinide analog, stimulates insulin release from the pancreas. This dual action helps control blood sugar levels, particularly after meals.
Vildagliptin is used in the treatment of type 2 diabetes mellitus. It is used along with diet and exercise to improve blood sugar control in adults with type 2 diabetes.
Sitagliptin phosphate and dapagliflozin tablets are a combination medication used to manage type 2 diabetes in adults. They work by enhancing insulin production and reducing glucose reabsorption in the kidneys.
Dapagliflozin + Linagliptin is a combination of two antidiabetic medications. Dapagliflozin works by lowering blood sugar levels in people with type 2 diabetes by excreting extra sugar from the body through urine.
